Gapping stocks in Friday's session
Monte Rosa Therapeutics Inc GLUE
$16.52
▼ -27.16%
($-6.16)
⬇️ Below Yest. Low
⚡ High Volume
🔥 High Short Interest
📅 Earnings This Week
Open
$15.47
Prev Close
$22.68
Day Range
$14.87 – $16.85
52W Range
$4.12 – $25.77
Market Cap
$1.40B
Beta
1.49
EPS (TTM)
$-1.46
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-06-24 |
| Shares Out. | 84,480,000 |
| Website | monterosatx.com/ ↗ |
| Phone | 16179492643 |
| Employees | 161 |
| Revenue | $4.2M |
| Gross Profit | $4.2M |
| Net Income | -$44.5M |
| Free Cash Flow | -$19.7M |
| Total Assets | $736.4M |
| Total Liabilities | $214.5M |
| Equity | $521.9M |
About Monte Rosa Therapeutics Inc
Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).
Monte Rosa Therapeutics Inc is a publicly traded company under the ticker symbol GLUE on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
15 analysts (2026-07-01)